Followers

July 24, 2024

US drug industry middlemen defend business model amid accusations of raising patient costs

​A House Committee on Oversight and Accountability report released earlier on Tuesday said it found evidence that these pharmacy benefit managers force drugmakers to pay rebates for placing their branded drugs in a favorable position on their lists of medications covered by various insurance plans.

from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/SO7N4qT

No comments:

Post a Comment